Cargando…
PB2183: RELAPSE PREDICTS POOR OUTCOMES IN FLT3-MUTATED ACUTE MYELOID LEUKEMIA POST ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431567/ http://dx.doi.org/10.1097/01.HS9.0000851560.91713.1c |
_version_ | 1784780090369900544 |
---|---|
author | Gavriilaki, E. Papalexandri, A. Mallouri, D. Batsis, I. Vardi, A. Bousiou, Z. Demosthenous, C. Panteliadou, A. Spyridis, N. Karavalakis, G. Touloumenidou, T. Masmanidou, M. Pistiolas, G. Mouladeniou, F. Vadikoliou, C. Lalayanni, C. Yannaki, E. Anagnostopoulos, A. Sakellari, I. |
author_facet | Gavriilaki, E. Papalexandri, A. Mallouri, D. Batsis, I. Vardi, A. Bousiou, Z. Demosthenous, C. Panteliadou, A. Spyridis, N. Karavalakis, G. Touloumenidou, T. Masmanidou, M. Pistiolas, G. Mouladeniou, F. Vadikoliou, C. Lalayanni, C. Yannaki, E. Anagnostopoulos, A. Sakellari, I. |
author_sort | Gavriilaki, E. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9431567 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-94315672022-08-31 PB2183: RELAPSE PREDICTS POOR OUTCOMES IN FLT3-MUTATED ACUTE MYELOID LEUKEMIA POST ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION Gavriilaki, E. Papalexandri, A. Mallouri, D. Batsis, I. Vardi, A. Bousiou, Z. Demosthenous, C. Panteliadou, A. Spyridis, N. Karavalakis, G. Touloumenidou, T. Masmanidou, M. Pistiolas, G. Mouladeniou, F. Vadikoliou, C. Lalayanni, C. Yannaki, E. Anagnostopoulos, A. Sakellari, I. Hemasphere Publication Only Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9431567/ http://dx.doi.org/10.1097/01.HS9.0000851560.91713.1c Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Publication Only Gavriilaki, E. Papalexandri, A. Mallouri, D. Batsis, I. Vardi, A. Bousiou, Z. Demosthenous, C. Panteliadou, A. Spyridis, N. Karavalakis, G. Touloumenidou, T. Masmanidou, M. Pistiolas, G. Mouladeniou, F. Vadikoliou, C. Lalayanni, C. Yannaki, E. Anagnostopoulos, A. Sakellari, I. PB2183: RELAPSE PREDICTS POOR OUTCOMES IN FLT3-MUTATED ACUTE MYELOID LEUKEMIA POST ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION |
title | PB2183: RELAPSE PREDICTS POOR OUTCOMES IN FLT3-MUTATED ACUTE MYELOID LEUKEMIA POST ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION |
title_full | PB2183: RELAPSE PREDICTS POOR OUTCOMES IN FLT3-MUTATED ACUTE MYELOID LEUKEMIA POST ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION |
title_fullStr | PB2183: RELAPSE PREDICTS POOR OUTCOMES IN FLT3-MUTATED ACUTE MYELOID LEUKEMIA POST ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION |
title_full_unstemmed | PB2183: RELAPSE PREDICTS POOR OUTCOMES IN FLT3-MUTATED ACUTE MYELOID LEUKEMIA POST ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION |
title_short | PB2183: RELAPSE PREDICTS POOR OUTCOMES IN FLT3-MUTATED ACUTE MYELOID LEUKEMIA POST ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION |
title_sort | pb2183: relapse predicts poor outcomes in flt3-mutated acute myeloid leukemia post allogeneic hematopoietic cell transplantation |
topic | Publication Only |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431567/ http://dx.doi.org/10.1097/01.HS9.0000851560.91713.1c |
work_keys_str_mv | AT gavriilakie pb2183relapsepredictspooroutcomesinflt3mutatedacutemyeloidleukemiapostallogeneichematopoieticcelltransplantation AT papalexandria pb2183relapsepredictspooroutcomesinflt3mutatedacutemyeloidleukemiapostallogeneichematopoieticcelltransplantation AT mallourid pb2183relapsepredictspooroutcomesinflt3mutatedacutemyeloidleukemiapostallogeneichematopoieticcelltransplantation AT batsisi pb2183relapsepredictspooroutcomesinflt3mutatedacutemyeloidleukemiapostallogeneichematopoieticcelltransplantation AT vardia pb2183relapsepredictspooroutcomesinflt3mutatedacutemyeloidleukemiapostallogeneichematopoieticcelltransplantation AT bousiouz pb2183relapsepredictspooroutcomesinflt3mutatedacutemyeloidleukemiapostallogeneichematopoieticcelltransplantation AT demosthenousc pb2183relapsepredictspooroutcomesinflt3mutatedacutemyeloidleukemiapostallogeneichematopoieticcelltransplantation AT panteliadoua pb2183relapsepredictspooroutcomesinflt3mutatedacutemyeloidleukemiapostallogeneichematopoieticcelltransplantation AT spyridisn pb2183relapsepredictspooroutcomesinflt3mutatedacutemyeloidleukemiapostallogeneichematopoieticcelltransplantation AT karavalakisg pb2183relapsepredictspooroutcomesinflt3mutatedacutemyeloidleukemiapostallogeneichematopoieticcelltransplantation AT touloumenidout pb2183relapsepredictspooroutcomesinflt3mutatedacutemyeloidleukemiapostallogeneichematopoieticcelltransplantation AT masmanidoum pb2183relapsepredictspooroutcomesinflt3mutatedacutemyeloidleukemiapostallogeneichematopoieticcelltransplantation AT pistiolasg pb2183relapsepredictspooroutcomesinflt3mutatedacutemyeloidleukemiapostallogeneichematopoieticcelltransplantation AT mouladeniouf pb2183relapsepredictspooroutcomesinflt3mutatedacutemyeloidleukemiapostallogeneichematopoieticcelltransplantation AT vadikoliouc pb2183relapsepredictspooroutcomesinflt3mutatedacutemyeloidleukemiapostallogeneichematopoieticcelltransplantation AT lalayannic pb2183relapsepredictspooroutcomesinflt3mutatedacutemyeloidleukemiapostallogeneichematopoieticcelltransplantation AT yannakie pb2183relapsepredictspooroutcomesinflt3mutatedacutemyeloidleukemiapostallogeneichematopoieticcelltransplantation AT anagnostopoulosa pb2183relapsepredictspooroutcomesinflt3mutatedacutemyeloidleukemiapostallogeneichematopoieticcelltransplantation AT sakellarii pb2183relapsepredictspooroutcomesinflt3mutatedacutemyeloidleukemiapostallogeneichematopoieticcelltransplantation |